ASHM

Twitter  LinkedIn  Facebook  Vimeo  Search 

Contact Us |  Careers    MyASHM 

   

  • Register
  • Cart ()
  • All
  • Website
  • Resources
  • Courses
  • Forums
  • HIV
    • HIV
    • PrEP
    • HIV Prescriber Program
    • Find an HIV s100 Prescriber
    • HIV Training
    • Undetectable = Untransmittable
    • HIV Strategies & Policies
  • Hepatitis B
    • Hepatitis B
    • HBV Prescriber Program
    • Find an HBV s100 Prescriber
    • Hepatitis B Training
    • HBV Strategies & Policies
  • Hepatitis C
    • Hepatitis C
    • Management and Treatment
    • Trained Community Medical Practitioners
    • Hepatitis C Training
    • HCV Strategies + Policies
    • Aus GPs End Hep C
    • Hepatitis C Elimination INHSU Declaration
  • Sexual Health
    • Sexual Health
    • Australasian Sexual Health Alliance
    • STI Strategies & Policies
    • STI Resources
    • STI Training
  • International
    • International
    • International Services
    • International Projects
    • Consultancy Pool
    • International Resources
    • Regional Network
    • Donate
  • Programs
    • Programs
    • Nursing Program
    • Aboriginal and Torres Strait Islander Program
    • Community Pharmacy
    • Viral Hepatitis Mapping Project
    • Our work in QLD
    • Our work in VIC
    • Culturally and Linguistically Diverse Program
    • Our work in HTLV-1
  • Resources
    • Resources
    • HIV Resources
    • HBV Resources
    • HCV Resources
    • STI Resources
  • Conferences
    • Conferences
    • Conferences We Organize
    • Our Conference Services
    • Our Team
    • Our Clients
    • Scholarships and Awards
    • Levinia Crooks Emerging Leader Award
    • Sector Events
  • Training
    • Training
    • Training Locator Map: Enter your Address or City
    • Kirby Seminar Talks
    • ASHM/SSHC HIV/Sexual Health Clinical Education Session
    • Contact Us
    • Training Calendar
  • About

ASHM Logo 2020

  • HIV
    • HIV
    • PrEP
    • HIV Prescriber Program
    • Find an HIV s100 Prescriber
    • HIV Training
    • Undetectable = Untransmittable
    • HIV Strategies & Policies
  • Hepatitis B
    • Hepatitis B
    • HBV Prescriber Program
    • Find an HBV s100 Prescriber
    • Hepatitis B Training
    • HBV Strategies & Policies
  • Hepatitis C
    • Hepatitis C
    • Management and Treatment
    • Trained Community Medical Practitioners
    • Hepatitis C Training
    • HCV Strategies + Policies
    • Aus GPs End Hep C
    • Hepatitis C Elimination INHSU Declaration
  • Sexual Health
    • Sexual Health
    • Australasian Sexual Health Alliance
    • STI Strategies & Policies
    • STI Resources
    • STI Training
  • International
    • International
    • International Services
    • International Projects
    • Consultancy Pool
    • International Resources
    • Regional Network
    • Donate
  • Programs
    • Programs
    • Nursing Program
    • Aboriginal and Torres Strait Islander Program
    • Community Pharmacy
    • Viral Hepatitis Mapping Project
    • Our work in QLD
    • Our work in VIC
    • Culturally and Linguistically Diverse Program
    • Our work in HTLV-1
  • Resources
    • Resources
    • HIV Resources
    • HBV Resources
    • HCV Resources
    • STI Resources
  • Conferences
    • Conferences
    • Conferences We Organize
    • Our Conference Services
    • Our Team
    • Our Clients
    • Scholarships and Awards
    • Levinia Crooks Emerging Leader Award
    • Sector Events
  • Training
    • Training
    • Training Locator Map: Enter your Address or City
    • Kirby Seminar Talks
    • ASHM/SSHC HIV/Sexual Health Clinical Education Session
    • Contact Us
    • Training Calendar
  • About
  • Australia | Supporting HIV, Viral Hepatitis and Sexual Health Workforce
  • Report Back<p style="color: #000; font-size: 16px; margin-top: 20px;"> Since 2015, the <a href="http://ashm.org.au/about/scholarships-and-awards/">ASHM Scholarship Program</a> provides a variety of scholarships to assist <a href="http://www.ashm.org.au/about/membership/">ASHM members</a>, affiliates and others in the HIV, viral hepatitis and sexual health sector to attend national and international conferences to support their continuing professional development. Scholarships have previously been awarded to HIV and HBV S100 prescribers (GP/Primary care), Sexual Health physicians, hospital-based specialists managing HIV, nurses and community pharmacists – who all are required to report back to colleagues and peers with their key learnings from the conferences shared in the format of <b>REPORT BACK blogs</b> with content focusing on translating science into clinical practice. <b>Below are conferences that are part of the ASHM Scholarship Program:</b></br></p><p style="text-align: center; margin-left: auto;margin-right: auto; display: block;"><a href="http://ashm.org.au/report-back/HIVAUS19/"><img alt="" src="https://ashm.org.au/about/ashm/HIVAIDS19-SH-Logo.jpg" style="width: 300px;"> </a><a href="https://ashm.org.au/report-back/EACS2019/"><img alt="EACS2019" src="https://ashm.org.au/about/thumbnail_image001.jpg" style="width: 200px;"> </a></p>
  • HIV&AIDS and Sexual Health Conferences 2019
  • Treatment and management

HIV&AIDS and Sexual Health Conferences 2019 Treatment and management

  1. Integrated Clinical Models of Care in People with HIV

    Zohreh Aminzadeh Barforoushi – Fri, 27 Sep 2019 02:00:00 GMT – 0

    The occurrence of some malignancies (ano-genital cancer and Hodgkin Lymphoma) in people with HIV (PWHIV) are increasing and cancers comprise of one third of Non-AIDS events in PWHIV. Approximately, 18% of cancer cases are caused by infection and 12% are caused by one of seven human tumour viruses (Hepatitis B and C, HTLV, Merkel Cell Polyomavirus, HPV, EBV, Kaposi Sarcoma Herpesvirus). Overall, HIV positive people with cancer have worse survival.

    Continue reading…

    • HIV co-morbidities
    • Treatment and management
  2. Syphylaxis?

    Sharon Robinson – Tue, 24 Sep 2019 02:30:00 GMT – 0

    A report back on Basil Donovan and Christopher Fairley's Debate: Doxycycline should be provided for syphilis prophylaxis in those at high risk. 

    As the Sexual Health conference came to a close, it was time for some light-hearted debate between Basil Donovan and Kit Fairley on the use of doxycycline as syphilis prophylaxis. The session Chair, Lewis Marshall, introduced the debate as being akin to all good duels, such as that between David and Goliath or Buzz Lightyear and Woody! Hang on…. aren’t Buzz and Woody on the same team? And in fact, this was a good predictor of what was to come. Basil was tasked with the affirmative and set about laying the ground work for the potential to all but eliminate the syphilis epidemic in 10 years if we could convince about half of all men who have sex with more than 20 male partners a year to take daily prophylaxis. It is our moral obligation in fact to provide such chemoprophylaxis if one exists. Basil downplayed any potential for side effects and antimicrobial resistance (reassuring us that all the antimicrobial resistance to doxycycline has already occurred – hardly reassuring) and added in the benefit that we could also potentially prevent chlamydia and gonorrhoea. “The community want it”, Basil says and seeing as it works so well for HIV, chemoprophylaxis for syphilis is the logical next step. 

    Continue reading…

    • sexual health
    • Treatment and management
  3. Time for women?

    Sharon Robinson – Tue, 24 Sep 2019 02:00:00 GMT – 0

    A report back on Deb Bateson, Moira Wilson, Rachael Dunn and Diane Lloyd's presentation HIV&AIDS symposium 19, HIV and women across the reproductive lifespan and beyond

    Wednesday afternoon saw the first session specifically for women living with HIV. The small meeting room was overflowing with every seat taken with not even standing room left. Diane Lloyd spoke of women’s invisibility during her 33 years of living with HIV in Australia and her point wasn’t lost on the audience. Deborah Bateson opened the session with a discussion of contraception choices for women living with HIV. While all methods are potentially suitable, interactions with enzyme inducing ARVs can cause issues with oral contraceptive pills and may lead to increased method failure. This can also cause a problem with levonorgestrel emergency contraception requiring a double dose. There was eager anticipation of the results of the ECHO trial from South Africa released in June this year which didn’t find any increase in HIV acquisition for women with the use of injectable progesterone contracepton despite years of concern.   

    Continue reading…

    • HIV and Pregnancy
    • Treatment and management
    • Women
  4. Emerging evidence - weight gain and INSTIs

    Nanette Presswell – Sun, 22 Sep 2019 22:00:00 GMT – 0

    A report on Professor Jenny Hoy's presentation New issues with INSTIs

    Professor Jenny Hoy gave an excellent presentation about the emerging evidence in relation to weight gain associated with integrase inhibitors, as well as an assessment of the clinical relevance of these findings.

    Continue reading…

    • HIV Treatment
    • Treatment and management
    • Women
  • ‹ Newer
  • Older ›

HIV&AIDS and Sexual Health Conferences 2019

ASHM Reporters @ Australasian HIV&AIDS and Sexual Health Conferences 2019

Options

Back to Blogs list RSS Feed

Search Blogs

  • This blog
  • All blogs

Tags

Aboriginal communities 2 CALD 1 Clinical assessment 1 GPs 1 HIV 2 HIV and Pregnancy 2 HIV co-morbidities 1 HIV Criminalisation 1 HIV Treatment 2 MSM 2 Peer-based 2 PrEP and STIs 3 sexual health 6 STI Treatment 1 Transgender 1 Treatment and management 4 Women 3

Archive

September 2019 17

ASHM

  • Home

    • Products
    • News
    • Store Locator
    • Careers
    • Sitemap
  • Community

    • Ideas
    • Blogs2

Privacy  |  Terms & Conditions  |  Contact Us  |  Copyright

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine  |  ABN 48 264 545 457  |  CFN 17788  |  Copyright © 2020. ASHM